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Abstract
Background: To determine whether resveratrol, a natural plant-derived drug, has protective
effects against antibody-induced apoptosis of retinal cells in vitro and to provide insights on the
mechanism of resveratrol protection.
Findings: E1A.NR3 retinal cells pretreated with 40 μM resveratrol were grown in the presence
of anti-recoverin (Rec-1), anti-enolase (Enol-1) antibodies, and normal purified immunoglobulins.
When the cells were exposed to resveratrol before treatment with Enol-1 or Rec-1 antibodies,
30–55% more cells survived compared to the resveratrol-untreated cells. Western blotting
showed a reduction in proapoptotic protein Bax in the cytoplasm and mitochondria of resveratrol-
treated cells. Resveratrol-pretreated cells also showed a significant decrease in intracellular calcium
and an inhibition of caspase-3 activity as compared to the untreated cells. Sirt1 expression was
greatly reduced in the cells grown in the presence of Rec-1 and Enol-1, but it increased about five
times in the resveratrol-pretreated cells. Immunocytochemistry revealed that Sirt1 expression in
the cytoplasm and nucleus was colocalized with Ku70 expression in resveratrol-treated cells,
suggesting possible interaction with each other in the cell. The pattern of the Ku70 cellular
localization also overlapped with the Bax cellular localization in treated and untreated cells.
Conclusion: In vitro protection of retinal cells from apoptosis by resveratrol occurred through
multiple early molecular events, such as reduction of intracellular calcium levels, down-regulation
of Bax, up-regulation of Sirt1 and Ku70 activities, and inhibition of caspase-3 activity. These findings
will help designing future in vivo and pre-clinical treatments for autoimmune retinopathies.
Background
Patients with autoimmune retinopathies (AR), including
cancer-associated retinopathy (CAR), suffer from retinal
degeneration and progressively lose their vision. Cur-
rently available corticosteroid and immunomodulation
therapies have limited roles in modifying the progression
of AR or CAR [1]. Therefore, a safe and reliable treatment
is urgently needed for these patients. Furthermore, age is
the strongest risk factor for the incidence of retinal degen-
eration in adult Americans [2]. The prevalence of vision
impairments and blindness increases after the age of 40
and is particularly rapid after age 75 [3]. We believe that
designing an effective therapy for the treatment of autoim-
mune retinopathies involves both understanding the dis-
ease mechanism and utilizing anti-aging mechanisms in
therapeutics.
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CAR and AR are associated with circulating autoantibod-
ies [4,5]. The most common autoantibodies found in
association with vision loss are against recoverin and α-
enolase [5]. In both cases, an increased intracellular cal-
cium ([Ca+2]i) caused by antibody triggered the apoptotic
pathway, and in patients, it can lead to degeneration of
photoreceptors in the retina [6-9]. In this study, we evalu-
ated the effect of resveratrol, a polyphenolic phytoalexin,
on levels of [Ca+2]i and on protection of retinal cells from
antibody-induced apoptotic death in vitro.
Resveratrol has strong anti-aging properties and has been
shown to play a neuroprotective role in several neurolog-
ical disorders [10-14] by protecting brain cells from death.
Recent studies also directly link the beneficial effects of
resveratrol to prevention of vision loss [15-18]. These
studies strongly suggest that resveratrol could be useful for
treating vision and neurological disorders associated with
diverse pathologies. The protective effects of resveratrol
on the retinal cells were examined in the in vitro study
using undifferentiated, immortalized rat retinal E1A.NR3
cells, which express markers specific for photoreceptors,
bipolar cells, ganglion cells, and retinal glial cells [19].
The molecular mechanism of resveratrol in cellular pro-
tection is not fully understood. Resveratrol acts by induc-
ing the anti-aging protein Sirt1 in organisms ranging from
yeasts to mammals [20,21]. Sirt1 exhibits anti-apoptotic
properties by deacetylating Ku70 protein in HEK293T kid-
ney cells [22]. Ku70, a DNA repair protein present in the
nucleus in its native deacetylated form, sequesters Bax in
the cytoplasm, and thereby performs a protective role in
the cell [23]. In our recent study on antibody-induced
apoptosis in retinal cells, the upregulated Bax translocated
to mitochondria and triggered mitochondria-mediated
caspase-3-mediated apoptosis and ultimately caused reti-
nal cell death [6,9]. We hypothesize that resveratrol upreg-
ulates Sirt1 and Ku70 in retinal cells and suppresses Bax in
the cytoplasm, therefore protecting cells from apoptotic
death induced by anti-retinal antibody.
Methods
MTT assay
E1A.NR3 cells [24] were grown in a 96-well microplate at
a density of 2 × 104/well in 100 μl volume with 0–40 μM
resveratrol for 16 hrs. 0.8 mg/ml of Rec-1 or Enol-1 were
added to the culture for another 72 hrs. The cell viability
was measured as described in a prior study [25].
Intracellular calcium assay
[Ca2+]i was measured using the Fluo-4 NW Calcium Assay
(Molecular Probes) as previously described [6]. Briefly, 2
× 104/well E1A.NR3 cells were grown in 96-well plates
overnight. Then 100 μl Fluo-4 NW dye was added for 30
min at 37°C. After adding 50 μl/well of antibody (0.8 mg/
ml of Enol-1, Rec-1, normal IgG) or thapsigargin (2 μM)
alone, or after 15 min pre-treatment with 40 μM resvera-
trol, measurements were made using an FLx800 Micro-
plate Fluorescence Reader (Bio-Tek Instruments, Inc.).
Cell fractionation
Cells (25 × 104) were pre-treated with 0–40 μM resveratrol
for 16 hrs, followed by incubation with 0.8 mg/ml of Rec-
1 or Enol-1 for 2 hrs. For total protein extraction, cells
were harvested, lysed, and centrifuged for 30 min at
15,000 g. Cytosolic and mitochondrial fractions of cells
treated with 0.8 mg/ml antibody for 45 min were
obtained as described in [6]. The protein content in each
fraction was determined using a BCA Protein Assay
(Pierce).
Western blotting
The blots containing 50 μg total, cytosolic or mitochon-
drial protein extracts were blocked in of 5% nonfat milk
in 0.1% Tween 20/PBS for 1 hr and then HRE-conjugated
antibodies were used as follows: 1:500 for mouse anti-Bax
(Santa Cruz Biotech), 1:500 for rabbit anti-Sirt1 (Santa
Cruz Biotech), 1:500 for goat anti-Ku70 (Santa Cruz Bio-
tech), 1:1000 for goat anti-α-tubulin (Santa Cruz Biotech)
and rabbit anti-Cox-IV (Cell Signaling) antibodies. Blots
were developed using LuminiGOLD ECL Western Blotting
Detection Kit (SgnaGen Lab) and exposed to an X-Omat
film (Kodak) until dark bands appeared. Blots were ana-
lyzed by densitometry using Kodak Digital Science 1D
Image Analysis software. α-tubulin was used as a control
for cytoplasmic and total proteins, and Cox-IV for mito-
chondrial proteins.
Immunofluorescence cytochemistry
Retinal cells were grown on a slide (2 × 104/well) over-
night pretreated with 40 μM resveratrol for 16 hrs and
then apoptosis was induced with 0.8 mg/ml Rec-1 or
Enol-1 for 2 hrs. Next, cells were washed, fixed in 4% para-
formaldehyde, and permeabilized with 0.3% Triton X-
100. After 30 min blocking with 1% BSA in PBS, one of
the following antibodies was added: mouse anti-Bax,
1:50; rabbit anti-Sirt1, 1:200; or goat anti-Ku70, 1:50
(Santa Cruz Biotech, Inc.) at 4°C overnight. Secondary
antibodies conjugated to fluorochromes (Alexa Fluor 488,
green and Alexa Fluor 594, red) (Invitrogen) were added
for 1 hr. The images were photographed under a Leica
DM5000B fluorescence microscope.
Determination of caspase-3 activity
5 × 105/well cells were grown overnight and 40 μM resver-
atrol was added 16 hrs before the induction of apoptosis
with 0.8 mg/ml Rec-1 or Enol-1 for 8, 16, and 24 hr in
triplicate. DMSO (0.5%) was used as a control. Following
antibody treatments, cells were harvested, lysed, and cen-
trifuged. A 50 μl supernatant was used for determiningBMC Research Notes 2008, 1:122 http://www.biomedcentral.com/1756-0500/1/122
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caspase-3 activity using an EnzChek caspase-3 fluorescent
assay (Molecular Probes). Caspase-3 activity was deter-
mined from a standard curve and normalized to the total
protein content in each sample.
Statistical analysis
Results are expressed as mean ± SE. The treatment differ-
ences were assessed by one-way ANOVAs and Mann-
Whitney t-tests. A P value less than 0.05 was considered
significant.
Results
Our previously published studies have established spe-
cific timelines for antibody-induced cell death, including
the rise of [Ca2+]i (3–30 min), expression of Bax (15–120
min), and activation of caspase-3 (16–24 hrs) in E1A-NR3
retinal cells following incubation with antibody
[5,6,9,24].
To determine whether resveratrol protects against Rec-1 or
Enol-1 induced cytotoxicity, retinal cells were grown in
the presence or absence of resveratrol and then exposed to
Eno-1 and Rec-1. Fig 1A shows marked protective effects
of 40 μM resveratrol on the antibody-induced apoptosis
in retinal cells. Without resveratrol, Rec-1 significantly
reduced cell survival to 45% and Enol-1 reduced the sur-
vival to 65% of the DMSO control (p < 0.01). To deter-
mine whether resveratrol acts as calcium channel blocker
and inhibits [Ca2+]i, we determined free [Ca2+]i in anti-
body/resveratrol treated cells. Treatment of retinal cells
with Rec-1 and Enol-1 caused small, but significant
increases in [Ca2+]i by 8% and 16%, respectively (p <
0.01), compared to normal IgG and untreated control (Fig
1B). When the cells were pretreated with 40 μM resvera-
trol for 15 min and then treated with Rec-1 and Enol-1,
the [Ca2+]i level stayed at statistically similar to the control
levels, suggesting that resveratrol inhibited [Ca2+]i
increases. To test if resveratrol could restore the SERCA
function, we used thapsigargin (TPG), a specific inhibitor
of SERCA, in the presence and absence of resveratrol [6].
2 μM TPG caused a significant increase of [Ca2+]i in the
control, indicating calcium release from intracellular
stores in the endoplasmic reticulum. In contrast, 40 μM
resveratrol pre-treatment effectively decreased the [Ca2+]i
(Fig 1C), suggesting that resveratrol may function as a cal-
cium channel blocker in the retinal cells.
To determine if resveratrol affects the expression of Bax,
we analyzed levels of Bax in the presence or absence of 40
μM resveratrol followed by induction of apoptosis for 45
min. Fig 2A shows that in the cytoplasm of resveratrol-
treated cells, Bax expression stayed at 1-fold compared to
2.5-fold increase in Rec-1 and 2-fold increase in Enol-1
treatments (Fig. 2A). Bax expression was 2- and 4.5-fold
greater in the Rec-1 and Enol-1 treated mitochondria,
respectively, as compared to untreated cells or cells pre-
treated with resveratrol prior to antibody treatment (Fig
2B). These results suggest that resveratrol may inihibit the
overexpression of Bax in both cytoplasm and mitochon-
dria as early as 45 min, and thereby preventing the mito-
chondria-mediated apoptosis. In the next experiment, we
determined whether resveratrol affected caspase-3 activa-
tion in the retinal cells during apoptosis. Fig 2C shows
caspase-3 activities in the cells exposed to 16-hr resvera-
trol treatment, and then exposed to Enol-1 or Rec-1 for 8,
16 and 24 hrs. There was no difference in the caspase-3
activity among the treatments after 8-hr; however, there
was a significant reduction in caspase-3 activity in resver-
atrol-pretreated cells for 16- and 24-hr as compared to
cells treated with Rec-1 (p < 0.01) and Enol-1 (p < 0.05)
alone. The inhibition of caspase-3 activity was probably
due to inactivation of Bax in the cytoplasm by resveratrol
in the early steps of the apoptotic events.
Next, we examined the effects of resveratrol on Sirt1 and
Ku70 expression during antibody-induced apoptosis. Fig
3A shows that about 5-fold Sirt1 increase in 40 μM resver-
atrol treated cells compared to untreated control, suggest-
ing that resveratrol may function as an effective Sirt1
activator in retinal cells. About 4 to 8 times Sirt1 increase
was observed in the resveratrol-pretreated cells that were
subsequently exposed to Enol-1 or Rec-1. Sirt1 expression
was at the control level in the Enol-1 and Rec-1 treat-
ments. Ku70 expression was nearly 3 times greater in the
resveratrol-pretreatment than in antibody alone (Fig 3B).
These results show that both antibodies suppressed the
expression of anti-apoptotic Sirt1 and Ku70 and resvera-
trol causes their upregulation, which lead to protection of
the cells from apoptosis.
Fig 4 shows fluorescent images of nuclei stained with
DAPI and immunofluorescent images of Bax, Ku70, and
SIRT1 in cells treated with resverarol and antibody or anti-
body alone. DMSO or NIgG controls showed only a min-
imal expression of Bax in the cytoplasm and Ku70 and
SIRT1 in the nucleus, but not in the cytoplasm. As
expected, Bax was dramatically upregulated by the Rec-1
and Enol-1 and was seen as thick green patches both in
the cytoplasm and in the peri nuclear regions, suggesting
the presence of Bax also in the mitochondria. Both Ku70
and SIRT1 increased in the resveratrol-treated cells,
whether or not the cells were grown with antibodies.
There was a strong immunofluorescent staining of Ku70
and SIRT1 in the nucleus and cytoplasm, indicating their
co-localization as shown by yellow color (Fig 4). Only a
negligible Ku70 staining was observed in the cytoplasm of
the cells treated with Enol-1 and Rec-1.
Discussion and conclusion
In this study, we showed for the first time the effects of the
anti-aging drug resveratrol against Rec-1 and Enol-1-
induced retinal cell death, using an in vitro model of anti-BMC Research Notes 2008, 1:122 http://www.biomedcentral.com/1756-0500/1/122
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Protection of retinal cells by resveratrol against antibody-induced cytotoxicity Figure 1
Protection of retinal cells by resveratrol against antibody-induced cytotoxicity. (A) E1A.NR3 cells were grown in 
96-well plates (100 μl) for 72 hr in the presence of 0.8 mg/ml purified Rec-1 or Enol-1 alone, or antibodies plus 40 μM resver-
atrol (Res). Cell survival was measured by MTT assay. Each treatment was replicated three times, and the bars represent an 
average percentage of cell survival for 3 experiments. The statistical significance of each treatment was estimated against con-
trols using one-way ANOVA and Mann-Whitney t-tests. ** = p < 0.01. (B) Effects of resveratrol on antibody-induced intracel-
lular [Ca2+] levels. Cells were incubated in a fluorescent dye for 30 min before the addition of 50 μl of 0.8 mg/ml Rec-1 and 
Enol-1 or (C) 2 μM thapsigargin (TPG), individually or after 15 min pre-treatment with 40 μM resveratrol. Each treatment was 
replicated three times and the experiment was repeated thrice. The statistical significance of each treatment was estimated 
against DMSO controls using one-way ANOVA and Mann-Whitney t-tests. * = p ≤ 0.05; ** = p ≤ 0.01.
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Molecular effects of resveratrol on pro-apoptotic proteins in E1A.NR3 retinal cells Figure 2
Molecular effects of resveratrol on pro-apoptotic proteins in E1A.NR3 retinal cells. Effects of resveratrol on Bax 
expression in the cytoplasm (A) and mitochondria (B). The retinal cells were treated with 40 μM resveratrol (Res) for 16 hrs 
followed by treatment with 0.8 mg/ml of Rec-1 and Enol-1 for 45 min. The protein expression was determined by Western 
blotting and the expression level is presented as a fold increase calculated from the intensity of each band compared to the 
untreated control after adjusting for the loading control using densitometry analyses. The bars represent an average of three 
experiments. (C) Effects of resveratrol on caspase-3 activity. The EnzChek Caspase-3 fluorescent assay was used to determine 
the protease activity of caspase-3 in E1A.NR3 cells in the presence and absence of 40 μM resveratrol pretreatment (16 hrs) 
followed by induction of apoptosis using 0.8 mg/ml of Rec-1 or Enol-1 for 8, 16, and 24 hrs. Each treatment was replicated 
three times and the experiment was repeated twice. The statistical significance of treatments under each time of exposure was 
estimated against vehicle control using two-way ANOVA and Mann-Whitney t-tests. * = p ≤ 0.05; ** = p ≤ 0.01.
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body-mediated retinopathy. Our findings demonstrate
that by blocking the elevation of [Ca2+]i levels early in the
apoptotic pathway, resveratrol reduced the expression of
pro-apoptotic Bax in the cytoplasm and mitochondrion.
This could be related to the increased expression of Sirt1
and Ku70 in resveratrol-treated cells, suggesting that the
upregulation of these proteins interfered with the pro-
apoptotic Bax movement to the mitochondria – essential
steps for mitochondria-mediated apoptotic cell death
[9,26,27]. Our findings support the hypothesis that Sirt1
deacetylates Ku70 and promotes its interaction with Bax
in the cytoplasm, thus preventing Bax translocation to
mitochondria [22]. Based on our results, we propose a
mechanism of the resveratrol protection from antibody-
induced apoptosis as illustrated in Fig 5, which shows that
antibodies enter the cell by endocytosis and induce
increased intracellular calcium levels, which in turn trig-
ger the mitochondria-mediated apoptotic cell death
[6,9,27]. Resveratrol blocks the influx of intracellular cal-
cium and the entry of Bax from the cytoplasm to mito-
chondria, which subsequently prevents caspase-3
activation and the cell death. If this mechanism of the res-
veratrol protection is confirmed in animal models of
Molecular effects of resveratrol on anti-apoptotic proteins Figure 3
Molecular effects of resveratrol on anti-apoptotic 
proteins. Effects of resveratrol on (A) Sirt1 and (B) Ku70 
expression in antibody-treated E1A-NR3 cells. The cells 
were pretreated with 40 μM resveratrol for 16 hrs followed 
by 2 hrs incubation in Enol-1 or Rec-1 antibodies. The pro-
tein cell extracts were analyzed by Western blotting using 
anti-Sirt1 and anti-Ku70 antibodies. Expression level is pre-
sented as a fold increase calculated from the intensity of each 
band compared to the untreated controls adjusted for the 
loading control using a densitometry analyses. The bars rep-
resent an average of three experiments.
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Immunofluorescent analysis of pro-and anti-apoptotic pro- teins Figure 4
Immunofluorescent analysis of pro-and anti-apop-
totic proteins. Immunofluorescent analysis of the expres-
sion of Bax (green), Ku70 (green), and Sirt1 (red) proteins in 
E1A.NR3 retinal cells in the presence and absence of 40 μM 
resveratrol pretreatment (16 hrs) followed by induction of 
apoptosis using 0.8 mg/ml of Rec-1 or Enol-1 for 2 hrs. The 
cells were incubated with anti-Bax, anti-Ku70 and anti-Sirt1 
antibodies followed by incubation in appropriate fluorescent 
secondary antibodies. Nuclei were stained with DAPI (blue) 
for 10 min. The images were photographed under a Leica 
DM5000B fluorescence microscope. Each treatment was 
replicated three times and the experiment was repeated 
twice. The arrows indicate the expression of corresponding 
proteins in the cytoplasm of nucleus.BMC Research Notes 2008, 1:122 http://www.biomedcentral.com/1756-0500/1/122
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retinopathy, resveratrol could be considered as a thera-
peutic drug for diseases, in which autoantibodies cause
retinal cell death. These findings and future in vivo studies
will serve as crucial pre-clinical experiments, upon which,
clinical studies can be designed.
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